Notably, hyperproliferation in lipedema ADSCs was suppressed by the serine/threonine kinase inhibitor 2OH‐BNPP1, which is a Bub1 inhibitor, and following CRISPR/Cas9‐mediated depletion of the Bub1 gene [55]. Here, BUB1 is linked to Lipedema.